V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161125 | 20062229 | 1.72 | 75.5 | Adjuvant (A) | 2016-05-23 | 2016-06-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100517441 |
| 20161126 | 20062230 | 1.5 | 80 | Adjuvant (A) | 2017-02-04 | 2020-01-25 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100435216 |
| 20161127 | 20062231 | 1.72 | 73.7 | Neo-adjuvant (N) | 2018-05-23 | 2018-05-28 | ECX | N | null | ECX | 101731971 |
| 20161128 | 20062232 | 1.75 | 77 | Palliative (P) | 2017-08-14 | 2017-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101382984 |
| 20161132 | 20062233 | 1.85 | 55.2 | Palliative (P) | 2019-09-20 | 2019-09-20 | ECX | 02 | N | ECX | 100313685 |
| 20161135 | 20062234 | 1.81 | 60.3 | Palliative (P) | 2016-02-13 | 2016-03-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100360050 |
| 20161136 | 20062235 | 1.7 | 62.3 | Palliative (P) | 2016-03-11 | 2016-03-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101670290 |
| 20161138 | 20062236 | 1.58 | 69 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-07 | Gemcitabine + Capecitabine | null | N | ECX | 101249121 |
| 20161139 | 20062237 | 1.73 | 76 | Palliative (P) | 2019-07-25 | 2019-08-13 | ECX | N | N | ECX | 101491468 |
| 20161140 | 20062238 | 1.61 | 83.5 | Palliative (P) | 2018-06-01 | 2018-06-12 | Gemcitabine + Capecitabine | N | Y | CAPECITABINE + GEMCITABINE | 101147997 |
| 20161141 | 20062239 | 1.76 | 82 | Palliative (P) | 2021-09-16 | 2021-09-23 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100903533 |
| 20161143 | 20062240 | 1.75 | 66.35 | null | 2016-11-23 | 2016-12-08 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101490592 |
| 20161144 | 20062241 | 1.51 | 55.6 | Adjuvant (A) | 2017-01-16 | 2017-01-16 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101418975 |
| 20161145 | 20062242 | 1.77 | 81.8 | Palliative (P) | 2017-06-04 | 2017-06-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101162354 |
| 20161146 | 20062243 | 1.64 | 70 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-23 | ECX | N | N | ECX | 100519047 |
| 20161148 | 20062244 | 1.6 | 53.4 | Adjuvant (A) | 2018-04-16 | 2018-04-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100528106 |
| 20161149 | 20062245 | 1.67 | 76.3 | Adjuvant (A) | 2020-02-05 | 2020-02-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101141519 |
| 20161150 | 20062246 | 1.65 | 68.2 | Palliative (P) | 2020-01-09 | 2020-01-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100714550 |
| 20161151 | 20062247 | 1.7 | 78.7 | Adjuvant (A) | 2017-02-12 | 2017-02-24 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100034468 |
| 20161152 | 20062248 | 1.66 | 69.2 | Neo-adjuvant (N) | 2020-04-02 | 2020-04-09 | ECX | 2 | N | ECX | 100096417 |
| 20161155 | 20062249 | 1.78 | 68.5 | Palliative (P) | 2017-02-27 | 2017-03-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100320992 |
| 20161157 | 20062250 | 1.59 | 81 | Neo-adjuvant (N) | 2018-12-10 | 2018-12-23 | ECX | N | N | ECX | 101098039 |
| 20161158 | 20062251 | 1.76 | 60 | Palliative (P) | 2016-06-25 | 2016-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101666090 |
| 20161161 | 20062252 | 1.79 | 46.4 | Neo-adjuvant (N) | 2018-10-21 | 2018-11-10 | ECX | N | N | ECX | 101266105 |
| 20161162 | 20062253 | 1.8 | 78.5 | Neo-adjuvant (N) | 2018-06-20 | 2018-06-28 | ECX | N | null | ECX | 100906767 |
| 20161163 | 20062254 | 1.64 | 100 | null | 2017-06-30 | 2017-07-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100864233 |
| 20161164 | 20062255 | 1.7 | 93.6 | Neo-adjuvant (N) | 2017-08-31 | 2017-09-08 | ECX | null | N | ECX | 100780614 |
| 20161166 | 20062256 | 1.52 | 75 | Curative (C) | 2018-12-30 | 2018-12-30 | ECX | N | N | ECX | 101259489 |
| 20161169 | 20062257 | 1.76 | 72.7 | Neo-adjuvant (N) | null | 2019-07-20 | ECX | N | N | ECX | 100923920 |
| 20161170 | 20062258 | 1.72 | 51 | Neo-adjuvant (N) | 2018-12-07 | 2019-01-24 | ECX | 02 | N | ECX | 101866188 |
| 20161173 | 20062259 | 1.8 | 103 | Curative (C) | 2020-02-22 | 2020-03-04 | ECX | N | N | ECX | 101230606 |
| 20161174 | 20062260 | 1.75 | 98.2 | Adjuvant (A) | 2017-05-07 | 2017-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100056684 |
| 20161177 | 20062261 | 1.53 | 52 | Curative (C) | 2019-05-02 | 2019-05-15 | ECX | N | N | ECX | 100586541 |
| 20161178 | 20062262 | 1.66 | 80.6 | Palliative (P) | 2016-02-10 | 2016-02-29 | ECX | N | N | ECX | 101559915 |
| 20161179 | 20062263 | 1.58 | 66.7 | Palliative (P) | 2018-01-05 | 2018-01-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101306101 |
| 20161181 | 20062264 | 1.6 | 59.8 | Adjuvant (A) | 2018-06-24 | 2018-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100819638 |
| 20161183 | 20062265 | 1.84 | 72.8 | Palliative (P) | 2017-06-03 | 2017-06-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100782073 |
| 20161186 | 20062266 | 1.59 | 64.9 | Adjuvant (A) | 2017-09-04 | 2017-09-04 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101219735 |
| 20161188 | 20062267 | 1.6 | 52.7 | Neo-adjuvant (N) | 2018-03-04 | 2018-03-19 | ECX | N | null | ECX | 100389957 |
| 20161190 | 20062268 | 1.68 | 66.75 | Neo-adjuvant (N) | 2017-04-26 | 2017-05-17 | ECX | N | null | ECX | 101036484 |
| 20161191 | 20062269 | 1.57 | 99.3 | Palliative (P) | 2016-11-14 | 2016-11-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101074052 |
| 20161192 | 20062270 | 1.74 | 81.6 | Adjuvant (A) | 2017-04-11 | 2017-04-15 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100641155 |
| 20161193 | 20062271 | 1.76 | 68.2 | Neo-adjuvant (N) | 2016-09-21 | 2016-10-10 | ECX | 2 | null | ECX | 101456174 |
| 20161194 | 20062272 | 1.69 | 65.4 | Adjuvant (A) | 2017-09-28 | 2017-09-28 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100108916 |
| 20161199 | 20062273 | 1.78 | 78.6 | null | 2018-04-02 | 2018-04-08 | ECX | N | null | ECX | 100989596 |
| 20161200 | 20062274 | 1.62 | 58.1 | Neo-adjuvant (N) | 2016-03-03 | 2016-03-30 | ECX | N | N | ECX | 101841632 |
| 20161204 | 20062275 | 1.7 | 85.4 | Neo-adjuvant (N) | 2017-08-24 | 2017-08-31 | ECX | 02 | N | ECX | 101547286 |
| 20161206 | 20062276 | 1.8 | 91.4 | Neo-adjuvant (N) | 2016-12-29 | 2017-01-07 | ECX | N | N | ECX | 100478742 |
| 20161207 | 20062277 | 1.72 | 84.9 | Palliative (P) | 2016-09-27 | 2016-10-24 | ECX | N | N | ECX | 100694764 |
| 20161208 | 20062278 | 1.67 | 90 | Neo-adjuvant (N) | 2017-10-22 | 2017-10-30 | ECX | N | N | ECX | 100463564 |